Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Jason Coloma Files Form 144 for 34,501 Maze Therapeutics Shares

Jason V. Coloma, an officer at Maze Therapeutics, Inc., filed a Form 144 notice of proposed sale of 34,501 shares of common stock on November 2, 2026, through UBS Financial Services Inc. on the Nasdaq exchange.

Vinay Lochav | 02 November 2026

Fold Holdings Officer Dickman Files to Sell 6 Shares

Thomas J. Dickman, an officer of Fold Holdings, Inc., filed a Form 144 notice on November 2, 2026, proposing the sale of 6 shares of common stock with an aggregate market value of $3.31.

Manish Choudhary | 02 November 2026

Savchenko Plans Sale of 66,667 Critical Metals Shares

Officer Savchenko Sergey filed a Form 144 notice of proposed sale of 66,667 common shares of Critical Metals Corp. on November 2, 2026, with Oppenheimer & Co, Inc. acting as broker on NASDAQ.

Aditi Sarkar | 02 November 2026

Natera Officer Moshkevich Plans Sale of 3,000 Shares

Natera, Inc. officer Solomon Moshkevich filed a Form 144 notice on November 2, 2026, proposing to sell 3,000 shares of Natera common stock with an aggregate market value of $1,233,379.80, to be executed on or around that same date through Morgan Stanley Smith Barney …

Shwetambri Chauhan | 02 November 2026

Natera Officer Brophy Files Rule 144 Notice for 313 Shares

Natera, Inc. officer Michael Brophy filed a Form 144 notice of proposed sale of securities with the SEC on November 2, 2026, covering 313 shares of Natera common stock with an aggregate market value of $129,675.90, to be sold on NASDAQ.

Aakashdeep | 02 November 2026

Natera Officer John Fesko Plans Sale of 291 Shares

Natera, Inc. officer John Fesko filed a Form 144 notice of proposed sale with the SEC on November 2, 2026, covering 291 shares of Natera common stock with an aggregate market value of $120,561.30.

Nitish Kishor | 02 November 2026

Natera Officer Rabinowitz Plans 330-Share Rule 144 Sale

Natera, Inc. officer Daniel Rabinowitz filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 330 shares of Natera common stock through ETrade Corporation on NASDAQ.

Aditi Sarkar | 02 November 2026

Rabinowitz Plans 722-Share Natera Sale After RSU Vest

Matthew Rabinowitz, a director of Natera, Inc., filed a Form 144 notice of proposed sale on November 2, 2026, covering 722 shares of Natera common stock acquired through restricted stock unit vesting on October 31, 2026.

Aditi Sarkar | 02 November 2026

Natera Director Jonathan Sheena Files to Sell 108 Shares

Jonathan Sheena, a director of Natera, Inc., filed a Form 144 notice of proposed sale on November 2, 2026, disclosing plans to sell 108 shares of Natera common stock with an aggregate market value of $44,744.40, through ETrade Corporation on NASDAQ.

Anjali Anand | 02 November 2026

Vaxcyte Officer Elvia Cowan Plans to Sell 3,000 Shares

Vaxcyte, Inc. officer Elvia Cowan filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 3,000 shares of Vaxcyte common stock on NASDAQ, acquired the same day through the exercise of stock options.

Anjali Anand | 02 November 2026
Support

Hi! How can we help you today?

Loading…